Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet regimen for managing HIV infection. This medication combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the virus's ability to multiply within the body, remarkably lowering the viral burden. For